Avelumab first-line maintenance (1LM) in patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) in the Czech Republic: Interim real-world results from a national reimbursement registry.
| Autor: | Zemankova, Anezka, Studentova, Hana, Melichar, Bohuslav, Eid, Michal, Poprach, Alexandr, Kopecky, Jindrich, Spacek, Jan, Stuhlova, Sarka, Dvorak, Jan, Vlcek, Pavel, Zychackova, Katerina, Katolicka, Jana, Blazek, Tomas, Vrana, David, Majkova, Petra, Cepa, Adam, Fiala, Ondrej |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p557-557, 193p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|